The transaction covered the sale of 852.913 shares, which constitutes 10% of Synektik shares and the same amount of the total number of votes in the company. The total value of the transaction was over PLN 190 million.
Following the completion of the sale, Książek Holding will hold 1,376,143 of Synektik shares, representing approximately 16.13% of the company's share capital. The shares were sold only to selected institutional investors and outside the United States of America under Regulation S pursuant to the U.S. Securities Act of 1933, as amended.
The project was led by Dr Michał Pawłowski, Managing Partner and Dr hab. Rafał Woźniak, Partner, supported by Mateusz Bąk, Senior Associate from the Corporate and M&A Department.
In connection with ABB, Santander Bank Polska S.A. - Santander Biuro Maklerskie and Banco Santander, S.A. acted as the Sole Global Coordinator and Bookrunner.
Synektik Group is a leading provider of innovative products, services and IT solutions for surgery, diagnostic imaging and nuclear medicine.
